Compile Data Set for Download or QSAR
Report error Found 31 of affinity data for UniProtKB/TrEMBL: Q8NBQ5
TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632086(CHEMBL5394877 | US20250340546, Example 8)
Affinity DataIC50: 263nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50365463(CHEMBL1232461)
Affinity DataIC50: 620nMAssay Description:Inhibition of HSD17B11 (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784428(US20250340546, Example 29)
Affinity DataIC50: 991nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784419(US20250340546, Example 20)
Affinity DataIC50: 992nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784427(US20250340546, Example 28)
Affinity DataIC50: 1.11E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784418(US20250340546, Example 19)
Affinity DataIC50: 1.21E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784422(US20250340546, Example 23)
Affinity DataIC50: 1.74E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632088(CHEMBL5411903 | US20250340546, Example 30)
Affinity DataIC50: 2.26E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784423(US20250340546, Example 24)
Affinity DataIC50: 2.52E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 3.26E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784413(US20250340546, Example 14)
Affinity DataIC50: 3.54E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632090(CHEMBL5426101 | US20250340546, Example 1)
Affinity DataIC50: 4.21E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784421(US20250340546, Example 22)
Affinity DataIC50: 5.04E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784415(US20250340546, Example 16)
Affinity DataIC50: 5.90E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784410(US20250340546, Example 11)
Affinity DataIC50: 5.94E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632076(CHEMBL5405439 | US20250340546, Example 9)
Affinity DataIC50: 6.09E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784420(US20250340546, Example 21)
Affinity DataIC50: 6.32E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784426(US20250340546, Example 27)
Affinity DataIC50: 6.64E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632078(CHEMBL5429503 | US20250340546, Example 18)
Affinity DataIC50: 7.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632084(CHEMBL5423975 | US20250340546, Example 10)
Affinity DataIC50: 8.26E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784401(US20250340546, Example 2)
Affinity DataIC50: 8.61E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632085(CHEMBL5405782 | US20250340546, Example 6)
Affinity DataIC50: 8.63E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784416(US20250340546, Example 17)
Affinity DataIC50: 8.69E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632044(CHEMBL5417785)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human full-length C-terminal His-tagged HSD17B11 using estradiol and NAD as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632089(CHEMBL5307400 | US20250340546, Example 7)
Affinity DataIC50: 1.00E+4nMAssay Description:Uncompetitive inhibition of recombinant human full-length C-terminal His-tagged HSD17B11 using estradiol and NAD as substrate preincubated for 10 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784425(US20250340546, Example 26)
Affinity DataIC50: 1.02E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784403(US20250340546, Example 4)
Affinity DataIC50: 1.03E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784424(US20250340546, Example 25)
Affinity DataIC50: 1.03E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632087(CHEMBL5417980 | US20250340546, Example 13)
Affinity DataIC50: 1.03E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632089(CHEMBL5307400 | US20250340546, Example 7)
Affinity DataIC50: 1.03E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM784411(US20250340546, Example 12)
Affinity DataIC50: 1.03E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent